Doxazosin Tablet
Product Images NDC 68071-4273

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 68071-4273). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4273 3

NuCare Pharmaceuticals Inc. has produced Doxazosin 2mg tablets with lots #000000 and #006000. The tablets are yellow and cream-colored, scored and round. They are available in packs of 30 tablets, each containing 2 mg of Doxazosin Mesylate USP. The expiration date is 00-00. The FDA regulates NuCare Pharmaceuticals Inc. Customers are advised to store the drug at a controlled temperature (59-86°F) and to contact their doctor for advice on possible side effects. If needed, they can report side effects to FDA at 1.800-FDA-1085. The product carries a warning to keep out of the reach of children.*

FDA Label Image

Table 1 (Doxazosin Fig1)

This is a table summarizing effectiveness data in placebo-controlled trials. The table shows the maximum flow rate, symptom score, baseline, and change in baseline for several studies. Study 1 had a titration of maximum dose of Vatinum Fo, while study 2 had a titration to a fixed dose of 14 weeks. Study 3 had a fixed dose of 12 weeks. The questionnaire used was the AUA questionnaire with a range of 0 to 30 in studies 1 and 3. Modified Boyarsiy questionnaire with a range of 7 to 39 in study 2. The endpoint change is different for the fixed-dose eye. There are several different dosages and drugs that were used in the studies.*

FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

This appears to be a table or chart showing the mean increase in maximum urinary flow rate and mean change in total symptom score from baseline for a group of subjects receiving a treatment compared to a placebo. The duration of treatment is also indicated. There is a note mentioning something about a medication called Doxazosi Titaton up to a maximum dose of 8 mg.*

FDA Label Image

Chemical Structure (Doxazosin Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.